Coronavirus disease 2019 (COVID‐19) infection has the potential for targeting the central
nervous system, and several neurological symptoms have been described in patients with …

Objective To report clinical and laboratory characteristics, treatment, and clinical outcomes
of patients admitted for neurologic diseases with and without coronavirus disease 2019 (…

Objective Single cases and small series of Guillain-Barré syndrome (GBS) have been
reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical …

Frontotemporal dementia (FTD) is a highly heritable condition with multiple genetic causes.
In this study, similarities and differences of gray matter (GM) atrophy patterns were assessed …

Background Neurofilament light chain (NfL) is a promising blood biomarker in genetic
frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN…

Objective This study aimed to assess whether non‐invasive brain stimulation with transcranial
alternating current stimulation at gamma‐frequency (γ‐tACS) applied over the precuneus …

Objective To assess the diagnostic and prognostic value of serum neurofilament light (NfL)
and serum phospho-Tau 181 (p-Tau 181 ) in a large cohort of patients with frontotemporal …

Background and purpose Many single cases and small series of Guillain–Barré syndrome (GBS)
associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) …

Background: It is still unknown if serum glial fibrillary acidic protein (GFAP) is a useful marker
in frontotemporal lobar degeneration (FTLD). Objective: To assess the diagnostic and …

Importance Behavioral disturbances are core features of frontotemporal dementia (FTD);
however, symptom progression across the course of disease is not well characterized in …